Humacyte, Inc. (NASDAQ:HUMA) Q4 2022 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte Fourth Quarter and Year-End 2022 Results Conference Call. Currently, all participants are in a listen-only mode.
Stay updated with breaking news from Human Acellular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte Fourth Quarter and Year-End 2022 Results Conference Call. Currently, all participants are in a listen-only mode.
GuruFocus Article or News written by GuruFocusNews and the topic is about:
27.06.2022 - Industry leader brings deep expertise in international drug development, strategic leadership, and corporate partnering for biopharmaceutical companiesDURHAM, N.C., June 27, 2022 (GLOBE NEWSWIRE) - Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage ...
Industry leader brings deep expertise in international drug development, strategic leadership, and corporate partnering for biopharmaceutical companies...
GuruFocus Article or News written by GuruFocusNews and the topic is about: